May & Baker Nigeria Plc has assured its customers of improved quality in its products on completion of its N3billion World Health Organisation (WHO) Standard Pharmaceutical Plant in Ota, OgunState .

Managing Director, May & Baker Nigeria Plc, Mr. Nnamdi Okafor said this at the company’s 2011 Customers’ Forum held in Lagos .

Okafor who revealed that the plant was near completion, noted that it would give the company extra capacity for many product lines.

“On completion, it would improve our output for liquid to 25 billion units and that tablet to 4 billion units. Very soon, production will commence and a good number of products will now be made in that factory. We are informing you (the Customers) because we know you are going to be in a position to help us pass on these extra outputs to the consumers.

“This year, we are re-emphasising the concept of partnership with you (the customers). Indeed as a company, we have decided to move a step ahead in our desire to satisfy customers, so we have changed one of our core values from ‘Customer Delight to Customer Intimacy. We seek to grow our relationship by making you part of our business,” he said.

On the score card for the immediate past year, Okafor described the year as a very difficult one for the pharmaceutical industry.

He added: “Our key strategies for higher performance this year are stronger support for our brands, broadening of our product offering and expected increase in output. Taking the advice freely offered by many of you, we have launched into new market segments, including multivitamins. The affordable medicines for malaria (AMFM) scheme has already kicked off.”